Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neural Tube Defects: early-phase trial registry
4 of 6 indexed Neural Tube Defects trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Neural Tube Defects: 6 US clinical trials tracked, 4 recruiting.
Neural Tube Defects is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Michael A Belfort, running 1 of these trials.
Enrollment posture brief
Registry condition neural-tube-defects
OPEN 4 | RECR 67% | LATE 0 | EARLY 1 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)
Neural Tube Defects lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neural Tube Defects on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neural Tube Defects is recruiting above its size-band peers.
4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Neural Tube Defects research.
Michael A Belfort accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Most Neural Tube Defects trials plan to enrol fewer than 100 people.
Median target enrolment is 38 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.
-
Neural Tube Defects research is mostly interventional.
5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
In-Utero Endoscopic Correction of Spina Bifida
University of Southern California
NCT04362592
Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases
Michael A Belfort
NCT05672849
Fetoscopic Neural Tube Defect Repair
Oregon Health and Science University
NCT06946563
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
USFetus
NCT03856034
Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study
Baylor College of Medicine
NCT03794011
Fetoscopic Repair of Isolated Fetal Spina Bifida
Johns Hopkins University
NCT03090633
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Neural Tube Defects records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neural Tube Defects trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neural Tube Defects page
6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Neural Tube Defects trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Michael A Belfort sponsors the most Neural Tube Defects trials on record, review their full trial history before evaluating a specific study. See Michael A Belfort's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neural Tube Defects condition card totals 6 registered trials; most-linked intervention Fetoscopy; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.